Send us a text

Quentin Anstee, Louise Campbell, Stephen Harrison, Mazen Noureddin, Ian Rowe and Roger Green convene to review #ILC2021 and share key takeaways and insights. This conversation covers issues around diagnostics.

The conversation covered several issues relating to use and interpretation of non-invasive testing. Two issues addressed use on NITs in diagnostics and, separately, drug development. A third considered how to develop and support end points generated around non-invasive tests instead of biopsy. In the process, the group discussed the shortcomings of biopsy as a gold standard as well as the practical challenges that keep biopsy in its current place in the hierarchy of test options.